<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma"</p><p>BMC Cancer 2005;5():119-119.</p><p>Published online 20 Sep 2005</p><p>PMCID:PMC1266025.</p><p>Copyright © 2005 Lee et al; licensee BioMed Central Ltd.</p>amplifications of and in three samples for each cell line were analysed to determine the relative levels of expression using the BioRad iCycler. All /ratios were close to 1 indicating that there are comparable amounts of both templates in each RNA samples. (B) Dilutions of a single RNA sample for each cell line were also amplified in triplicate with both gene primer sets to confirm that the ratio was consistent regardless of starting template...
<p><b>Copyright information:</b></p><p>Taken from "Identification of novel androgen receptor target ...
<p>A) Example of the RT qPCR analysis of EpCAM (left) and beta actin (right) mRNA amounts in SKOV3 c...
OBJECTIVE: To interrogate enriched prostate cancer cells and autologous non-malignant prostate epith...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
Background: \ud \ud The EphB4 receptor tyrosine kinase has been reported as increased in tumours ori...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
Prostate Cancer is the most commonly diagnosed cancer and the second most common cause of cancer dea...
The EphB4 receptor tyrosine kinase is over-expressed in a variety of different epithelial cancers in...
© 2001 Stephenson et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copyi...
<p>Real-time RT-PCR was used for quantification of (A) EpoR mRNA and (C) Epo mRNA, western blot for ...
<p><b>Copyright information:</b></p><p>Taken from "Identification of novel androgen receptor target ...
Contains fulltext : 47521.pdf (publisher's version ) (Closed access)For interpreta...
<p><b>Copyright information:</b></p><p>Taken from "Identification of novel androgen receptor target ...
<p>A) Example of the RT qPCR analysis of EpCAM (left) and beta actin (right) mRNA amounts in SKOV3 c...
OBJECTIVE: To interrogate enriched prostate cancer cells and autologous non-malignant prostate epith...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
Background: \ud \ud The EphB4 receptor tyrosine kinase has been reported as increased in tumours ori...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 rece...
Prostate Cancer is the most commonly diagnosed cancer and the second most common cause of cancer dea...
The EphB4 receptor tyrosine kinase is over-expressed in a variety of different epithelial cancers in...
© 2001 Stephenson et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copyi...
<p>Real-time RT-PCR was used for quantification of (A) EpoR mRNA and (C) Epo mRNA, western blot for ...
<p><b>Copyright information:</b></p><p>Taken from "Identification of novel androgen receptor target ...
Contains fulltext : 47521.pdf (publisher's version ) (Closed access)For interpreta...
<p><b>Copyright information:</b></p><p>Taken from "Identification of novel androgen receptor target ...
<p>A) Example of the RT qPCR analysis of EpCAM (left) and beta actin (right) mRNA amounts in SKOV3 c...
OBJECTIVE: To interrogate enriched prostate cancer cells and autologous non-malignant prostate epith...